MARKET

CDIO

CDIO

Cardio Diagnostics Holdings Inc
NASDAQ
2.005
-0.025
-1.23%
Opening 13:26 06/25 EDT
OPEN
2.050
PREV CLOSE
2.030
HIGH
2.120
LOW
2.005
VOLUME
12.87K
TURNOVER
--
52 WEEK HIGH
7.91
52 WEEK LOW
0.9700
MARKET CAP
5.93M
P/E (TTM)
-0.5937
1D
5D
1M
3M
1Y
5Y
1D
Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians
TipRanks · 1d ago
Cardio Diagnostics announces AHP to cover Epi+Gen CHD, PrecisionCHD
TipRanks · 1d ago
Cardio Diagnostics tests gain coverage at Atlas Healthcare Physicians network from May 2026
PUBT · 1d ago
Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI
TipRanks · 2d ago
Weekly Report: what happened at CDIO last week (0615-0619)?
Weekly Report · 3d ago
Cardio Diagnostics Holdings (NASDAQ: CDIO) Aligns with Growing Shift Toward Predictive, Precision Medicine
TipRanks · 06/18 18:00
Cardio Diagnostics Holdings (NASDAQ: CDIO) Working to Help Employers Tackle Cardiovascular Risk, Healthcare Costs
TipRanks · 06/16 19:30
Cardio Diagnostics (NASDAQ: CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection
TipRanks · 06/15 17:30
More
About CDIO
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Webull offers Cardio Diagnostics Holdings Inc stock information, including NASDAQ: CDIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDIO stock methods without spending real money on the virtual paper trading platform.